MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Precise evaluation and exercise prescription for Parkinson’s disease

H. Ziyi (Dalian, China)

Meeting: MDS Virtual Congress 2020

Abstract Number: 1226

Keywords: Gait disorders: Treatment, Parkinsonism, Rehabilitation

Category: Physical Therapy, Speech Therapy, Rehabilitation

Objective: To study the intervention effect of the exercise prescription centered on Baduanjin for patients with early Parkinson’s disease, and to explore the possibility of applying the British VICON three-dimensional motion capture system to Parkinson’s disease evaluation.

Background: Parkinson’s disease (PD) is a serious progressive neurodegenerative disease characterized by motor and non-motor disorders. The most common motor symptoms of the disease include resting tremor, myotonia, bradykinesia, and posture disorders.

Method: Twenty PD patients were selected, and Parkinson’s patients were divided into two groups. One was a drug-only treatment group, the drug dose remained unchanged for 12 weeks, and the other was a sports prescription group. The exercise prescription of the center and exercise according to the prescription. The two groups were evaluated PD-related clinical data around 12 weeks. The British VICON three-dimensional motion capture system was used to detect changes in gait parameters of patients with Parkinson’s disease, and all data were statistically analyzed. The analysis and statistics tool is SPSS 22.0 software.

Results: After exercise training group, UPDRSⅢ, standing phase%, swing phase%, double support phase%, step length, stride length, stride speed HAMA, PDQ39 all improved significantly than before (P> 0.05), the difference is statistically significant; HAMD There was an improvement over the previous one, but the amplitude was not significant (P <0.05), and there was no statistical difference. After treatment in the drug treatment group, UPDRSⅢ improved significantly compared with the previous one (P> 0.05), and the difference was statistically significant; HAMA, HAMD, PDQ39, standing phase%, swing phase%, double support phase%, step length, stride, and pace There was improvement before, but the amplitude was not significant (P <0.05), and there was no statistical difference.

Conclusion: Exercise prescription can improve the walking ability, daily activity ability and anxiety of patients with Parkinson’s disease. Considering that the improvement of depression is not obvious, consider that it may be related to the decline in motivation of patients with depression. Compared with the updrs scale, the gait analysis system increases sensitivity and objectivity

To cite this abstract in AMA style:

H. Ziyi. Precise evaluation and exercise prescription for Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/precise-evaluation-and-exercise-prescription-for-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/precise-evaluation-and-exercise-prescription-for-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley